PD-1/PD-L1 PPI immune checkpoint inhibitor (Sun Yat-Sen University/Zunyi Medical University/Guizhou Minzu University)

N/A

Report date: 2025/03/20 15:37:38

Base Information

Drug NamePD-1/PD-L1 PPI immune checkpoint inhibitor (Sun Yat-Sen University/Zunyi Medical University/Guizhou Minzu University)
Drug Alias Namegramicidin S cyclopeptide analogues (Sun Yat-Sen University/Zunyi Medical University/Guizhou Minzu University)PD-1/PD-L1 protein-protein interaction inhibitor (Sun Yat-Sen University/Zunyi Medical University/Guizhou Minzu University)dual PD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Sun Yat-Sen University/Zunyi Medical University/Guizhou Minzu University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesZunyi Medical UniversityGuizhou Minzu UniversitySun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A